The medication mix-up began August 7 when Resident #5 returned from a neurologist appointment with new orders for carbidopa-levodopa, the primary medication for treating Parkinson's disease. The neurologist's summary contained conflicting information that confused nursing staff about the correct dosing.
According to the inspection report, the summary's narrative section described one medication regimen, while the initial and ending medication lists showed different doses entirely. Staff focused on a section stating "no changes to the medications" and ignored the treatment plan that outlined the actual prescription changes.
The facility's Director of Nursing acknowledged the confusion but admitted staff didn't call the neurologist's office for clarification after the August 7 visit. Instead, they implemented what they thought were the correct orders.
From August 8 through August 20, the resident received only one tablet of carbidopa-levodopa four times daily instead of the prescribed 2.5 tablets five times daily. He also didn't receive any extended-release tablets that were part of his treatment plan.
The inadequate dosing forced staff to use emergency "PRN" medication 31 times during those 12 days. Each PRN dose was 2.5 tablets given every five hours as needed for breakthrough symptoms.
By August 18, nursing staff realized something was wrong. A progress note from that date showed the Director of Nursing called the neurologist's office because "the PRN wasn't enough" and the resident "was super stiff with this order."
The Director of Nursing requested a change to 2.5 tablets scheduled four times daily with one tablet five times daily as needed. She told the neurologist's office that the current regimen was inadequate for managing the resident's symptoms.
The neurologist responded with surprise the following day. A telephone message dated August 19 asked, "Why is he getting 1 tab 4 times a day? He should be getting 2.5 tabs 5 times a day and Sinemet Extended Release 50/200 one tablet 5 times a day."
This response revealed the extent of the medication error. The resident should have been receiving both the higher dose of regular carbidopa-levodopa and extended-release tablets throughout the nearly two-week period.
The facility's Administrator acknowledged during the October inspection that the neurologist's summary from August 7 contained contradictory information. She said staff saw the entry about no medication changes and found it confusing given the conflicting details elsewhere in the summary.
The Administrator explained that nursing staff typically wouldn't pay attention to the section titled "Plan" in medical summaries, focusing instead on other portions of the documentation.
Federal inspectors found that the facility's medication order policy didn't require further validation of written transfer orders if they were signed and dated by the attending physician, unless the orders were unclear or incomplete. However, staff failed to seek clarification despite acknowledging the contradictory nature of the neurologist's summary.
The medication error affected the resident's quality of life for nearly two weeks. Parkinson's disease causes progressive loss of muscle control, and carbidopa-levodopa helps manage symptoms like rigidity, tremor, and difficulty moving.
When patients don't receive adequate doses, they experience increased stiffness and reduced mobility. The resident's need for 31 emergency doses over 12 days demonstrated the severity of his undertreated symptoms.
The Director of Nursing's description of the resident as "super stiff" reflected the clinical reality of inadequate Parkinson's medication. Muscle rigidity can make basic activities like walking, eating, and changing positions extremely difficult.
The inspection occurred more than two months after the medication error was corrected, suggesting the incident came to light through a complaint rather than internal facility reporting. Federal inspectors classified the violation as causing minimal harm or potential for actual harm to few residents.
The case illustrates the importance of clear communication between medical providers and nursing facilities, particularly for complex neurological conditions requiring precise medication management. The resident's prolonged discomfort could have been avoided with a simple clarification call to the neurologist's office.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Casa De Paz Health Care Center from 2025-10-30 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Casa De Paz Health Care Center
- Browse all IA nursing home inspections